JuiceBiotech (02367.HK) intends to repurchase shares according to the repurchase authorization.

Intelligence Finance APP News, Juzi Biotech (02367.HK) announced that it proposed to grant the general authorization to repurchase shares. The board of directors hereby announced its intention to exercise the power granted by the shareholders at the company's annual general meeting held on June 13, 2025 to grant the directors the general authorization to repurchase company shares. Under the share buyback authorization, the company is authorized to repurchase up to 104 million shares, which is 10% of the number of issued shares (excluding treasury shares) on the day of the resolution passed by the annual general meeting of shareholders. This authorization shall expire on the earliest of the following events: (i) the end of the next annual general meeting of shareholders, or (ii) the date on which the articles of association or other applicable laws stipulate the deadline for holding the next annual general meeting of shareholders, or (iii) the date on which the share repurchase authorization is revoked or amended by the shareholders at the general meeting by ordinary resolution.